Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-26 15:00 |
Fourth Quarter and Fiscal Year 2024 Financial Results and conference call on Ma…
|
English | 36.4 KB | ||
| 2025-01-22 14:58 |
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZI…
|
English | 143.2 KB | ||
| 2025-01-22 14:58 |
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZI…
|
English | 36.4 KB | ||
| 2025-01-08 15:24 |
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-…
|
English | 12.5 MB | ||
| 2025-01-08 15:24 |
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-…
|
English | 41.3 KB | ||
| 2025-01-08 14:59 |
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-…
|
English | 122.5 KB | ||
| 2025-01-08 14:59 |
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-…
|
English | 38.2 KB | ||
| 2024-12-11 17:07 |
Annual General Meeting Results
|
English | 122.5 KB | ||
| 2024-12-11 17:07 |
Annual General Meeting Results
|
English | 36.1 KB | ||
| 2024-11-13 15:30 |
Third Quarter and Nine Month 2024 Financial Results
|
English | 4.3 MB | ||
| 2024-11-13 15:30 |
Third Quarter and Nine Month 2024 Financial Results
|
English | 36.3 KB | ||
| 2024-11-13 15:12 |
The company's financial results for third quarter for 2024 reported abroad
|
Hebrew (modern) | 62.4 KB | ||
| 2024-11-06 14:59 |
will release financial results s for the third quarter on November 13, 2024, an…
|
English | 150.1 KB | ||
| 2024-11-06 14:59 |
will release financial results s for the third quarter on November 13, 2024, an…
|
English | 36.4 KB | ||
| 2024-11-04 14:59 |
Kamada to Present at the Stifel 2024 Healthcare Conference
|
English | 123.1 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
